Crystal structure and biophysical characterisation of Helicobacter pylori phosphopantetheine adenylyltransferase

Biochemical and Biophysical Research Communications

Volumn 408, Issue 2, 2011, Pages 356-361

  Cheng, Chao Sheng ^a   Chen, Chih Hao ^a   Luo, Yong Chun ^a   Chen, Wen Tin ^a   Chang, Shun Ya ^a   Lyu, Ping Chiang ^a   Kao, Mou Chieh ^a   Yin, Hsien Sheng ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Coenzyme A; Dinucleotide binding fold; Helicobacter pylori; Phosphopantetheine adenylyltransferase

Indexed keywords

BACTERIAL ENZYME; COENZYME A; PANTETHEINE PHOSPHATE ADENYLYLTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; BIOPHYSICS; BIOSYNTHESIS; CRYSTAL STRUCTURE; ESCHERICHIA COLI; HELICOBACTER PYLORI; NONHUMAN; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; THERMOSTABILITY; ULTRACENTRIFUGATION;

AMINO ACID SEQUENCE; COENZYME A; CRYSTALLOGRAPHY, X-RAY; ENZYME STABILITY; ESCHERICHIA COLI; HELICOBACTER PYLORI; MOLECULAR SEQUENCE DATA; NUCLEOTIDYLTRANSFERASES; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; SPECTROPHOTOMETRY, ULTRAVIOLET;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HELICOBACTER PYLORI;

EID: 79955650450     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.058     Document Type: Article

References (32)

1. Hirai Y., Hayashi S., Shimomura H., Oguma K., Yokota K. Association of Helicobacter pylori with gastroduodenal diseases. Jpn. J. Infect. Dis. 1999, 52:183-197.
2. Proenca-Modena J.L., Acrani G.O., Brocchi M. Helicobacter pylori: phenotypes, genotypes and virulence genes. Future Microbiol. 2009, 4:223-240.
3. Atherton J.C. The pathogenesis of Helicobacter pylori -induced gastro-duodenal diseases. Annu. Rev. Pathol. 2006, 1:63-96.
4. Kusters J.G., van Vliet A.H.M., Kuipers E.J. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 2006, 19:449-490.
5. Mirbagheri S.A., Hasibi M., Abouzari M., Rashidi A. Triple Standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: A comparative three-armed randomized clinical trial. World J. Gastroenterol. 2006, 12:4888-4891.
6. Minakari M., Jazi A.H.D., Shavakhi A., Moghareabed N., Fatahi F. A randomized controlled trial: efficacy and safety of azithromycin, ofloxacin, bismuth, and omeprazole compared with amoxicillin, clarithromycin, bismuth, and omeprazole as second-line therapy in patients with Helicobacter pylori infection. Helicobacter 2010, 15:154-159.
7. Graham D.Y., Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat. Clin. Pract. Gastroenterol. Hepatol. 2008, 5:321-331.
8. Tomb J.F., White O., Kerlavage A.R., Clayton R.A., Sutton G.G., Fleischmann R.D., Ketchum K.A., Klenk H.P., Gill S., Dougherty B.A., Nelson K., Quackenbush J., Zhou L.X., Kirkness E.F., Peterson S., Loftus B., Richardson D., Dodson R., Khalak H.G., Glodek A., McKenney K., Fitzegerald L.M., Lee N., Adams M.D., Hickey E.K., Berg D.E., Gocayne J.D., Utterback T.R., Peterson J.D., Kelley J.M., Cotton M.D., Weldman J.M., Fujii C., Bowman C., Watthey L., Wallin E., Hayes W.S., Weidman J.M., Fujii C., Borodovsky M., Karp P.D., Smith H.O., Fraser C.M., Venter J.C. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997, 388:539-547.
9. Begley T.P., Kinsland C., Strauss E. The biosynthesis of coenzyme A in bacteria. Vitam. Horm. 2001, 61:157-171.
10. Jackowski S., Rock C.O. Metabolism of 4'-phosphopantetheine in Escherichia coli. J. Bacteriol. 1984, 158:115-120.
11. Sassetti C.M., Boyd D.H., Rubin E.J. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 2003, 48:77-84.
12. W.V. Shaw, A. Lewendon, Production and use of antimicrobial agents, European Patent Office WO0017387, 2000.
13. Bork P., Holm L., Koonin E.V., Sander C. The cytidylyltransferase superfamily- identification of the nucleotide-binding site and fold prediction. Proteins 1995, 22:259-266.
14. Geerlof A., Lewendon A., Shaw W.V. Purification and characterization of phosphopantetheine adenylyltransferase from Escherichia coli. J. Biol. Chem. 1999, 274:27105-27111.
15. Izard T., Geerlof A. The crystal structure of a novel bacterial adenylyltransferase reveals half of sites reactivity. EMBO J. 1999, 18:2021-2030.
16. Izard T. The crystal structures of phosphopantetheine adenylyltransferase with bound substrates reveal the enzyme's catalytic mechanism. J. Mol. Biol. 2002, 315:487-495.
17. Morris V.K., Izard T. Substrate-induced asymmetry and channel closure revealed by the apoenzyme structure of Mycobacterium tuberculosis phosphopantetheine adenylyltransferase. Protein Sci. 2004, 13:2547-2552.
18. Gerdes S.Y., Scholle M.D., D'Souza M., Bernal A., Baev M.V., Farrell M., Kurnasov O.V., Daugherty M.D., Mseeh F., Polanuyer B.M., Campbell J.W., Anantha S., Shatalin K.Y., Chowdhury S.A., Fonstein M.Y., Osterman A.L. From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways. J. Bacteriol. 2002, 184:4555-4572.
19. Izard T. A novel adenylate binding site confers phosphopantetheine adenylyltransferase interactions with coenzyme A. J. Bacteriol. 2003, 185:4074-4080.
20. Eom S.J., Ahn H.J., Kim H.W., Baek S.H., Suh S.W. Crystallization and preliminary X-ray crystallographic studies of phosphopantetheine adenylyltransferase from Helicobacter pylori. Acta Crystal. D 2003, 59:561-562.
21. Laemmli U.K. Cleavage of structural proteins during assembly of head of bacteriophage-T4. Nature 1970, 227:680-685.
22. Lebowitz J., Lewis M.S., Schuck P. Modern analytical ultracentrifugation in protein science: a tutorial review. Protein Sci. 2002, 11:2067-2079.
23. Cheng C.S., Chen M.N., Lai Y.T., Chen T., Lin K.F., Liu Y.J., Lyu P.C. Mutagenesis study of rice nonspecific lipid transfer protein 2 reveals residues that contribute to structure and ligand binding. Proteins 2008, 70:695-706.
24. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. Macromol. Cryst. A 1997, 276:307-326.
25. Vagin A., Teplyakov A. MOLREP: an automated program for molecular replacement. J. Appl. Crystallogr. 1997, 30:1022-1025.
26. Murshudov G.N., Vagin A.A., Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystal. D 1997, 53:240-255.
27. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystal. D 2004, 60:2126-2132.
28. Laskowski R.A., Macarthur M.W., Moss D.S., Thornton J.M. Procheck - a Program to Check the Stereochemical Quality of Protein Structures. J. Appl. Crystallogr. 1993, 26:283-291.
29. Armengaud J., Fernandez B., Chaumont V., Rollin-Genetet F., Finet S., Marchetti C., Myllykallio H., Vidaud C., Pellequer J.L., Gribaldo S., Forterre P., Gans P. Identification, purification, and characterization of an eukaryotic-like phosphopantetheine adenylyltransferase (coenzyme A biosynthetic pathway) in the hyperthermophilic archaeon Pyrococcus abyssi. J. Biol. Chem. 2003, 278:31078-31087.
30. Nalezkova M., de Groot A., Graf M., Gans P., Blanchard L. Overexpression and purification of Pyrococcus abyssi phosphopantetheine adenylyltransferase from an optimized synthetic gene for NMR studies. Protein Expr. Purif. 2005, 39:296-306.
31. Yuan Z., Zhao J., Wang Z.X. Flexibility analysis of enzyme active sites by crystallographic temperature factors. Protein Eng. 2003, 16:109-114.
32. Zhao L., Allanson N.M., Thomson S.P., Maclean J.K., Barker J.J., Primrose W.U., Tyler P.D., Lewendon A. Inhibitors of phosphopantetheine adenylyltransferase. Eur. J. Med. Chem. 2003, 38:345-349.